MLICM
YARW

Metropolitan Life Insurance Company (MetLife)’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14
Closed -$81.4K – 2575
2020
Q3 		$81.4K Buy
14
+3
+27% +$17.5K ﹤0.01% 2337
2020
Q2 		$66.5K Buy
+11
New +$74.5K ﹤0.01% 2458

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s YARW Position: Q4 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2020, closing a stake of 14 shares — an estimated $81.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in YARW in Q2 2020 and held it in 2 quarters. The position peaked at $81.4K in Q3 2020. 98 funds tracked by Wall St. Rank hold YARW as of Q4 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14 Yarrow Bioscience, Inc. Common Stock shares in Q4 2020, an estimated $81.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Yarrow Bioscience, Inc. Common Stock position peaked at $81.4K in Q3 2020.
  • 98 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.